Companies /Healthcare

Charles River Laboratories International Inc

NYSE: CRL Diagnostics & Research
$338.46
▼ $20.95 (−5.83%) today
Markets closed · 5:16pm ET
24/7 Rating HOLD
Our 12-month price target
$371.24
+3.3% upside by Nov 2027
Price when calculated $359.41 Nov 2, 2026
Street consensus $318.87 18 analysts
Ours vs. the Street +16.4% Our target vs. consensus

Set by 24/7 Wall St.’s proprietary analysis of professional targets, profit trajectory, sector, risk, and retail attention. Recalculated at least weekly and after every earnings report.

How we calculate it →
12-Month Projection Historical Optimistic Target Conservative
$160$240$320$400Nov 2025Nov 2027Nov 2$409.87$371.24$299.34
$160$240$320$400Nov 2025Nov 2027Nov 2$409.87$371.24$299.34

Analyst Sentiment

18ANALYSTS
Buy1583%
Hold211%
Sell16%
The Bottom Line

Charles River Laboratories is fairly valued at current levels. With our price target of $371.24 suggesting modest upside, the stock appears to be trading near fair value. Consider your portfolio allocation and investment timeline before making a decision.

The 24/7 Factor

Base Growth
Conservative growth baseline (reduced to avoid double-counting P/E growth)
1.05×
Sector Momentum
Defensive growth with aging population tailwinds
1.10×
Analyst Consensus
Strong analyst consensus (bullish)
+4.6%
Earnings Growth
Earnings pressure
−1.7%
Volatility Adjustment
Higher volatility stock
−0.8%
Price Position
Upper range of 52-week trading
+0.5%
Read our full methodology →

5-Year Projection

Long-Term Forecast Optimistic Target Conservative
$280$350$420$490’26’27’28’29’30’31$524.58$441.73$298.47
$280$350$420$490’26’27’28’29’30’31$524.58$441.73$298.47

Prediction History

CRL Price Target History Our Target Stock Price
$270$300$330$360Aug 7Oct 30$371.48$359.74
$270$300$330$360Aug 7Oct 30$371.48$359.74
$180$240$300$360May 28Oct 30$371.48$359.74
$180$240$300$360May 28Oct 30$371.48$359.74
Date Price Target Stock Price Rating Upside
$371.48 $359.74 HOLD +3.3%
$359.24 $345.37 HOLD +4.0%
$328.68 $300.25 BUY +9.5%
$326.86 $302.06 BUY +8.2%
$317.76 $290.15 BUY +9.5%
$311.02 $293.20 BUY +6.1%
$286.75 $278.06 HOLD +3.1%
$288.65 $278.26 HOLD +3.7%
Date Price Target Stock Price Rating Upside
$371.48 $359.74 HOLD +3.3%
$311.02 $293.20 BUY +6.1%
$314.56 $291.50 BUY +7.9%
$257.84 $234.62 BUY +9.9%
$232.36 $212.44 BUY +9.4%
$202.55 $184.28 BUY +9.9%

Frequently Asked Questions

What is the CRL stock price prediction for 2030?

Looking ahead to 2030, our model projects CRL could trade at an average price of $423.88, with a potential range between $317.91 and $529.85. This represents a potential 17.9% return from today’s price. Long-term forecasts depend heavily on company execution, competitive dynamics, and broader market conditions.

Is CRL a buy, sell, or hold right now?

24/7 Wall St. currently rates CRL as a HOLD. Near fair value (3.3%) Among Wall Street analysts, 15 rate it Buy, 2 rate it Hold, and 1 rate it Sell.

What is the CRL stock price target in an optimistic scenario?

In our optimistic scenario for CRL, the stock could reach $409.87 over the next 12 months, representing a 14.0% gain from today’s price. This scenario assumes favorable conditions materialize, including strong earnings growth, positive market sentiment, and successful execution of company initiatives.

What is the downside risk for CRL stock?

In our conservative scenario, CRL could trade as low as $299.34 over the next 12 months, representing a 16.7% decline from current levels. This scenario accounts for potential headwinds including earnings misses, competitive pressures, or broader market weakness.

Projections are estimates based on current data, updated daily. Not investment advice. Learn how we calculate these projections →